The Technical AnalystExchange: TWO Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Center Laboratories, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.92% TWD43.95
America/New_York / 7 mai 2024 @ 01:30
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 30 152 mill |
| EPS: | -1.500 |
| P/E: | -29.30 |
| Earnings Date: | May 03, 2024 |
| SharesOutstanding: | 686.06 mill |
| Avg Daily Volume: | 1.289 mill |
| RATING 2024-05-07 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Sell | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -29.30 | sector: PE 34.77 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -1.32x |
| Company: PE -29.30 | industry: PE 22.22 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
TWD-43.64 (-199.30%) TWD-87.59 |
| Date: 2024-05-07 |
| Expected Trading Range (DAY) |
|---|
|
TWD 43.06 - 44.84 ( +/- 2.03%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | TWD43.95 (0.92% ) |
| Volume | 1.160 mill |
| Avg. Vol. | 1.289 mill |
| % of Avg. Vol | 89.94 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 4123.TWO
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
4123.TWO
Center Laboratories, Inc. engages in the manufacture and trading of various medicines in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.